Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06522737 |
| Title | A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype (TERZO) |
| Acronym | TERZO |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | SecuraBio |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | POL | NLD | ITA | GBR | FRA | ESP | DNK | DEU | CZE |